Milica Vukmirovic, PhD

Milica Vukmirovic, PhD, holds the position of Blavatnik Fellow in Life Science Entrepreneurship at the Office of Cooperative Research (OCR) and Blavatnik Innovation Fund at Yale University. She works on commercialization of medical breakthrough innovations across Yale and assists Blavatnik Innovation Fund activities. She recently was elected as the Chair of the newly formed ATS RCMB Assembly working group on Innovation and Entrepreneurship.

Milica Vukmirovic previously served as a Venture Creation Consultant and Blavatnik Associate for OCR while she was an Associate Research Scientist in Dr N. Kaminski’s group at the Center for Precision Pulmonary Medicine at Yale. Milica’s research focused on understanding gene regulatory networks in Idiopathic Pulmonary Fibrosis (IPF), sarcoidosis and A1AT deficiency. Recently her focus is on the development of a novel anti-fibrotic drug for IPF.

Prior to coming to Yale, Milica was a Postdoctoral Fellow & Project Manager at the International Centre for Health Innovation, Ivey Business School at Western University, in Canada, where she evaluated several inventions to be adopted into the health care sector. She received a PhD in Life Sciences from the University of Lausanne, Switzerland, and was a Postdoctoral Associate at Florida State University, College of Medicine, where she performed research on fibrosis and in parallel, initiated a series of an Entrepreneurial Postdoctoral Panels.